Publications

Find at Harvard

Read Now

December 2008 (Revised October 2013)
Case

Amylin Pharmaceuticals: Diabetes and Beyond (A)

By: Richard G. Hamermesh and Rachel Gordon

Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time, the company has a... View Details

Keywords: Regulations; Drug Regulations; Symlin; Negotiation; Governing Rules, Regulations, and Reforms; Resource Allocation; Negotiation Deal; Product Development; Research and Development; Commercialization; Pharmaceutical Industry; United States

September 2008
Case

Pfizer Inc: Building an Innovation Center

By: Stefan H. Thomke and Ashok Nimgade

The case describes Pfizer's efforts to build and run an innovation center in Cambridge, Massachusetts. As the center goes through different periods of leadership and strategic models, its relationship with the corporation and other research sites is explored. The case... View Details

Keywords: Innovation and Management; Innovation Strategy; Leadership; Organizational Culture; Research and Development; Pharmaceutical Industry; Cambridge

October 2007
Case

Valuation at Novartis

By: Paul M. Healy

Keywords: Valuation; Pharmaceutical Industry

October 2006
Teaching Note

Merck Sharp & Dohme Argentina, Inc. (TN) (A) and (B) (LCA)

By: Lynn S. Paine

Keywords: Pharmaceutical Industry; Argentina

April 2006
Supplement

Vertex Pharmaceuticals: R&D Portfolio Management (C)

By: Francesca Gino and Gary P. Pisano

Keywords: Pharmaceutical Industry

April 2006
Supplement

Vertex Pharmaceuticals: R&D Portfolio Management (B)

By: Francesca Gino and Gary P. Pisano

Keywords: Pharmaceutical Industry

April 1989 (Revised July 1992)
Supplement

Technology Transfer: Anti-Inflammatory Drug (B)

By: Regina E. Herzlinger

Keywords: Health; Pharmaceutical Industry

Find at Harvard

February 2006 (Revised July 2007)
Case

Corporate Venture Capital at Eli Lilly

By: Richard G. Hamermesh, Ron Laufer and David Lane

Reviews the role of corporate venture capital and its history at Eli Lilly. Also presents a challenging venture investment opportunity. View Details

Keywords: Venture Capital; Investment; Pharmaceutical Industry

January 2006 (Revised July 2006)
Case

Drug Testing in Nigeria (A)

By: Debora L. Spar

In 1996, a meningitis epidemic swept across Nigeria. Thousands of children were struck and, lacking appropriate medicine, were liable to die from the disease. Doctors at Pfizer had an antibiotic that could probably save most of these children's lives. The drug was new,... View Details

Keywords: Risk and Uncertainty; Health Pandemics; Health Testing and Trials; Developing Countries and Economies; Pharmaceutical Industry; Nigeria

fall 2002
Article

Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial

By: Arthur A. Daemmrich

Keywords: Science; Health; Courts and Trials; Pharmaceutical Industry; Germany

Find at Harvard

March 2001 (Revised June 2017)
Teaching Note

Vyaderm Pharmaceuticals: The EVA Decision

By: Robert Simons and Indra A. Reinbergs

Teaching Note for (9-101-019). View Details

Keywords: Pharmaceutical Industry; Washington (state, US)

October 2000
Supplement

Hans Fritz at Novartis Thailand (C)

By: Carin-Isabel Knoop and Michael Y. Yoshino

Supplements the (A) case. View Details

Keywords: Pharmaceutical Industry; Thailand

October 2000
Case

Procter & Gamble Italy: The Pringles Launch (A)

By: Roy D. Shapiro

Procter & Gamble's (P&G) Pringles potato chips have been a very successful brand. This case reviews the development and first launch in the United States, then in markets around the world. Italy is one of the last countries where Pringles will be launched. Should P&G... View Details

Keywords: Globalized Markets and Industries; Brands and Branding; Marketing Strategy; Product Launch; Emerging Markets; Product Development; Adoption; Value Creation; Pharmaceutical Industry; United States

September 1999
Teaching Note

Eli Lilly: The Evista Project TN

By: Steven C. Wheelwright

Teaching Note for (9-699-016). View Details

Keywords: Pharmaceutical Industry

June 1998
Supplement

MBA Integrative Exercise: General Management, April 1998

By: Carin-Isabel Knoop

Drummond Paris, Regional Pharma Head, Asia/Pacific Novartis AG, discusses the company situation in Indonesia: joint ventures, budget, keeping track, and the prognosis for the future. View Details

Keywords: Business or Company Management; Joint Ventures; Forecasting and Prediction; Pharmaceutical Industry; Indonesia

October 1992 (Revised September 1993)
Case

Nopane Advertising Strategy

By: David E. Bell

Nopane is a proprietary drug that sells in much of the United States. It faces substantial competition. The brand manager is undertaking an experiment to determine whether ad copy should be emotional-based or rational-based. The data and associated regression results... View Details

Keywords: Competition; Intellectual Property; Advertising; Health Care and Treatment; Brands and Branding; Product Marketing; Pharmaceutical Industry; United States

February 1998 (Revised October 1998)
Background Note

Note on New Drug Development in the United States

By: Stefan H. Thomke and Ashok Nimgade

An overview of the new drug development process in the United States, using the migraine drug Imitrex as an illustrative example. View Details

Keywords: Product Development; Research and Development; Health; Pharmaceutical Industry; United States

February 1996 (Revised April 2004)
Case

Eli Lilly and Company: Innovation in Diabetes Care

By: Clayton M. Christensen

Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the... View Details

Keywords: Change; Product; Service Delivery; Product Development; Innovation and Management; Innovation Strategy; Health Care and Treatment; Pharmaceutical Industry